Investigation of bias in meta-analyses due to selective inclusion of trial effect estimates: empirical study
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Objective: To explore whether systematic reviewers selectively include trial effect estimates in meta-analyses when multiple are available, and what impact this may have on meta-analytic effects. Design: Cross-sectional study. Data sources: We randomly selected systematic reviews of interventions from 2 clinical specialties published between January 2010 and 2012. The first presented meta-analysis of a continuous outcome in each review was selected (index meta-analysis), and all trial effect estimates that were eligible for inclusion in the meta-analysis (eg, from multiple scales or time points) were extracted from trial reports. Analysis: We calculated a statistic (the Potential Bias Index (PBI)) to quantify and test for evidence of selective inclusion. The PBI ranges from 0 to 1; values above or below 0.5 are suggestive of selective inclusion of effect estimates more or less favourable to the intervention, respectively. The impact of any potential selective inclusion was investigated by comparing the index meta-analytic standardised mean difference (SMD) to the median of a randomly constructed distribution of meta-analytic SMDs (representing the meta-analytic SMD expected when there is no selective inclusion). Results: 31 reviews (250 trials) were included. The estimated PBI was 0.57 (95% CI 0.50 to 0.63), suggesting that trial effect estimates that were more favourable to the intervention were included in meta-analyses slightly more often than expected under a process consistent with random selection; however, the 95% CI included the null hypothesis of no selective inclusion. Any potential selective inclusion did not have an important impact on the meta-analytic effects. Conclusion: There was no clear evidence that selective inclusion of trial effect estimates occurred in this sample of meta-analyses. Further research on selective inclusion in other clinical specialties is needed. To enable readers to assess the risk of selective inclusion bias, we recommend that systematic reviewers report the methods used to select effect estimates to include in meta-analyses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Included studies may report multiple results that are eligible for inclusion within the review outcome definition.66 67”
From PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (2021) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Chapter 9: Analysing Data and Undertaking Meta-Analyses
Deeks, J. J., Higgins, J. P. T., & Altman, D. G. (2008) · Cited by 2,782
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
Analysing Data and Undertaking Meta‐Analyses
Deeks, J. J., Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch9 · Cited by 1,800
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
Dwan, K., Altman, D. G., Arnaiz, J. A., Bloom, J., Chan, A.-W., Cronin, E., Decullier, E., Easterbrook, P. J., Von Elm, E., Gamble, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003081 · Cited by 1,546
Dwan, K., Gamble, C., Williamson, P. R., Kirkham, J. J., & the Reporting Bias Group (2013) · PLoS ONE · doi:10.1371/journal.pone.0066844 · Cited by 1,127
Finding What Works in Health Care: Standards for Systematic Reviews
Eden, J., Levit, L. A., Berg, A. O., & Morton, S. C. (2013) · Cited by 943
Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0
Boers, M., Kirwan, J. R., Wells, G., Beaton, D., Gossec, L., d'Agostino, M.-A., Conaghan, P. G., Bingham, C. O., Brooks, P., Landewé, R., et al. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.11.013 · Cited by 781 · cited 1×
“Core outcome measurement sets are lists of measurement scales recommended for use in trials and systematic reviews of a particular health condition, and are designed to increase consistency in scale selection.(9) We therefore expected selective inclusion to be less common in reviews with a core outcome measurement set…”
BackgroundIndustry sponsorship and research outcome
Lundh, A., Sismondo, S., Lexchin, J., Busuioc, O. A., & Bero, L. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub2 · Cited by 605 · cited 1×
“Further, given the evidence of an association between industry funding and research outcomes, 21 there is bene fi t in exploring whether selective inclusion is more common in reviews funded by the sponsor of the product under investigation.”
BackgroundMurad, M. H., Montori, V. M., Ioannidis, J. P. A., Jaeschke, R., Devereaux, P. J., Prasad, K., Neumann, I., Carrasco-Labra, A., Agoritsas, T., Hatala, R., et al. (2014) · JAMA · doi:10.1001/jama.2014.5559 · Cited by 454 · cited 1×
“INTRODUCTION Systematic reviews and meta-analyses of healthcare intervention trials can contribute to improved patient care by providing valid and reliable information for healthcare decision-making.(1) However, the validity of systematic review findings can be compromised by challenges with undertaking meta-analysis.”
BackgroundFinding What Works in Health Care: Standards for Systematic Reviews
Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Board on Health Care Services, & Institute of Medicine (2011) · doi:10.17226/13059 · Cited by 289
Page, M. J., McKenzie, J. E., Kirkham, J., Dwan, K., Kramer, S., Green, S., & Forbes, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000035.pub2 · Cited by 281
Self-citationOsteoarthritis: rational approach to treating the individual
Jüni, P., Reichenbach, S., & Dieppe, P. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.05.002 · Cited by 237 · cited 1×
“We selected the conditions RA/OA and depressive/ anxiety disorders because we wanted to explore whether the existence of a core outcome measurement set for RA and OA trials 7 8 impacted on selective inclusion.”
MethodDwan, K., Altman, D. G., Clarke, M., Gamble, C., Higgins, J. P. T., Sterne, J. A. C., Williamson, P. R., & Kirkham, J. J. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001666 · Cited by 187
Outcome measures in rheumatoid arthritis randomised trials over the last 50 years
Kirkham, J. J., Boers, M., Tugwell, P., Clarke, M., & Williamson, P. R. (2013) · Trials · doi:10.1186/1745-6215-14-324 · Cited by 171 · cited 1×
“We selected the conditions RA/OA and depressive/ anxiety disorders because we wanted to explore whether the existence of a core outcome measurement set for RA and OA trials 7 8 impacted on selective inclusion.”
MethodAttention should be given to multiplicity issues in systematic reviews
Bender, R., Bunce, C., Clarke, M., Gates, S., Lange, S., Pace, N. L., & Thorlund, K. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.03.004 · Cited by 121 · cited 1×
“For example, systematic reviewers performing a meta-analysis of depression scores may encounter mean differences for two depression scales at three time points.(2) 3 Strengths and limitations of this study”
BackgroundIndustry Sponsorship and Research Outcome: A Cochrane Review
Bero, L. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.4190 · Cited by 109
Booth, A., Clarke, M., Ghersi, D., Moher, D., Petticrew, M., & Stewart, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027319 · Cited by 96 · cited 1×
“3 16 19 However, we believe decision rules for other sources of multiplicity (eg, unadjusted and covariate-adjusted analyses, analyses undertaken on multiple samples such as intention-to-treat and per-protocol) also deserve consideration.”
BackgroundPage, M., Mckenzie, J., & Forbes, A. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.10.010 · Cited by 71 · cited 1×
“However, in some cases, the selection may be based on the nature or direction of the estimates themselves; 4 this is analogous to when triallists perform multiple analyses of the same outcome, yet only report that which is most favourable.”
BackgroundSelf-citationMultiplicity of data in trial reports and the reliability of meta-analyses: empirical study
Tendal, B., Nuesch, E., Higgins, J. P. T., Juni, P., & Gotzsche, P. C. (2011) · BMJ · doi:10.1136/bmj.d4829 · Cited by 60 · cited 2×
“There was potential for large and clinically important variability in the resulting meta-analytic effects depending on which trial effect estimates were included.(3) However, there has been no empirical investigation of whether systematic reviewers selectively include trial effect estimates in meta-analyses when multi…”
BackgroundPage, M. J., McKenzie, J. E., Chau, M., Green, S., & Forbes, A. B. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.02.009 · Cited by 22 · cited 1×
“However, we believe decision rules for other sources of multiplicity (eg, unadjusted and covariate-adjusted analyses, analyses undertaken on multiple samples such as intention-to-treat and per-protocol) also deserve consideration.(20) When deciding which methods to prespecify, authors should consider issues such as th…”
BackgroundSelf-citationPage, M. J., McKenzie, J. E., Green, S., & Forbes, A. B. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-21 · Cited by 9 · cited 3×
“We constructed a statistical test based on the PBI to test whether the observed selection of effect estimates is consistent with randomness of selection.(6) Confidence limits (95%) for the PBI were obtained by bootstrap resampling.”
MethodInfluentialSelf-citation
Research works printed but not linked: 1
- Fu R, Vandermeer BW, Shamliyan T Chapter 14: handling continuous outcomes in quantitative synthesis. In: Methods guide for effectiveness and comparative effectiveness reviews, AHRQ Publication No. 10(14)-EHC063-EF. Rockville, MD: Agency for Healthcare Research and Quality, 2014 http://www.effectivehealthcare.ahrq.gov 24006546
Cited by
Page, M. J., Moher, D., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n160 · Cited by 13,262
Self-citationPage, M. J., Moher, D., Bossuyt, P., Boutron, I., Hoffmann, T., mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S. E., et al. (2020) · doi:10.31222/osf.io/gwdhk · Cited by 916
Self-citationRegistration of systematic reviews in PROSPERO: 30,000 records and counting
Page, M. J., Shamseer, L., & Tricco, A. C. (2018) · Systematic Reviews · doi:10.1186/s13643-018-0699-4 · Cited by 509
“However, we expect the number of errors to be low given the extensive experience that the data collector (MJP) has from recording this type of information in previous studies [1, 14, 17, 22].”
BackgroundSelf-citationMayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., & Dickersin, K. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.05.007 · Cited by 131
“trialists [15, 16] and systematic reviewers to cherry-pick [17, 35, 19, 21].”
BackgroundTreatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
Flacco, M. E., Martellucci, C. A., Bravi, F., Parruti, G., Cappadona, R., Mascitelli, A., Manfredini, R., Mantovani, L. G., & Manzoli, L. (2020) · Heart · doi:10.1136/heartjnl-2020-317336 · Cited by 113
Metadata
- Authors
- Page, M. J., Forbes, A., Chau, M., Green, S. E., & McKenzie, J. E.
- Affiliations
- University of Bristol (GB)
- Monash University (AU)
- National Trauma Research Institute (AU)
- Corresponding author
- McKenzie, Joanne E
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2016-04
- Volume
- 6
- Issue
- 4
- Pages
- e011863
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC4853995
- OpenAlex
- W2344534501
- Semantic Scholar
- 52364981656d87794c30e41d5c7ae95b94e3eabe
- Cited by
- 23
- References
- 23
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2021: 6 · 2020: 3 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 1
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion, cc-by-nc)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion, cc-by-nc)
- Funders
- Monash University
- National Health and Medical Research Council (1088535, 1072366)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Social Sciences › Library and Information Sciences › scientometrics and bibliometrics research
- Keywords
- meta-analysis, systematic reviews, reporting bias
- MeSH terms
- Cross-Sectional Studies, Humans, Research Design, Meta-Analysis as Topic, Selection Bias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.